COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

03/07/2017 - 13:18

Bagsværd, Denmark, 3 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company

03/07/2017 - 13:00

Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company Horizon's reference standards [...]

Shire plc : Total voting rights

03/07/2017 - 13:00

Total Voting Rights July 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the [...]

Solon Eiendom ASA : Sales in Q2 2017

03/07/2017 - 09:07

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Sales in Q2 2017 Oslo, July 3, 2017 - Solon Eiendom sold 68 homes with a total sales value of NOK 685 million during the second quarter of 2017 compared [...]

Total number of shares and voting rights in Zealand at June 30, 2017

03/07/2017 - 08:40

Company announcement - No. 24 / 2017 Total number of shares and voting rights in Zealand at June 30, 2017 Copenhagen, July 3, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure [...]

Zealand initiates first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes

03/07/2017 - 08:28

Company announcement - No. 23/2017 Zealand initiates first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes First patients enrolled in a multinational Phase 3 clinical trial of [...]

Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline

03/07/2017 - 08:00

PRESS RELEASE Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline (Oxford, UK and Conshocken, US, 3 July 2017) Immunocore Limited, the world's leading TCR company [...]

Keynote Presentation Reports Lack of Knowledge on Clinical Advances Achieved by the New Generation of Biomarker Tests for Prostate Cancer

03/07/2017 - 07:00

Independent Survey Results Presented at the 5th Global Congress on Prostate Cancer (PROSCA) Indicate Untapped Market Potential for SelectMDx NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and [...]

Présentation liminaire fait état d'un manque de connaissances des avancées cliniques réalisées par la nouvelle génération de tests par biomarqueurs pour le cancer de la prostate

03/07/2017 - 07:00

Résultats de sondage indépendant présentés lors du 5ième congrès mondial sur le cancer de la prostate (PROSCA) indiquent un potentiel de marché inexploité pour SelectMDx COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE [...]

Targovax ASA: Commencement of subscription period for the subsequent offering

03/07/2017 - 07:00

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Fagron redeems bond loan

03/07/2017 - 07:00

Regulated information Nazareth (Belgium) / Rotterdam (The Netherlands), 3 July 2017 Fagron redeems bond loan Fagron announces that the bond loan of € 225 million will be redeemed in full today. The bond loan, which was [...]

Bone Therapeutics SA: Strengthens Board of Directors

03/07/2017 - 07:00

Bone Therapeutics Strengthens Board of Directors Steve Swinson elected as Chairman of the Board of Bone Therapeutics Dirk Dembski appointed as Non-Executive Director, bolstering the Board with additional orthopaedic and [...]

Bone Therapeutics SA : Renforce son Conseil d'administration

03/07/2017 - 07:00

Bone Therapeutics renforce son Conseil d'administration Steve Swinson est élu Président du Conseil d'administration de Bone Therapeutics Dirk Dembski, nommé en qualité d'administrateur indépendant, apporte au Conseil [...]

New Study with Abiomed's Impella 2.5® Heart Pump Demonstrates Potential Survival with Pre-PCI Insertion in Heart Attacks with the Left Main Coronary Artery

30/06/2017 - 14:17

DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a peer-reviewed [...]

Targovax ASA: Approval and publication of prospectus; the subsequent offering

30/06/2017 - 13:42

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

30/06/2017 - 09:48

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Integrums bokslutskommuniké 1 maj 2016 - 30 april 2017

30/06/2017 - 08:32

PRESSINFORMATION 30 juni 2017 Integrum AB (publ) ("Integrum" eller "Bolaget") redovisade en nettoomsättning på 17 811 (12 324) KSEK under perioden 2016-05-01 till 2017-04-30 (12 månader), en ökning med 45 % jämfört med [...]

VALNEVA annonce le succès de son Assemblée Générale et la nomination de deux nouveaux membres à son Conseil de Surveillance

30/06/2017 - 07:00

Valneva annonce le succès de son Assemblée Générale et la nomination de deux nouveaux membres à son Conseil de Surveillance; Le Groupe confirme sa stratégie de croissance et ses perspectives R&D Lyon (France), 30 [...]

VALNEVA Announces Successful Outcome of its AGM and the Appointment of two new Supervisory Board Members

30/06/2017 - 07:00

Valneva Announces Successful Outcome of its AGM and the Appointment of two new Supervisory Board Members; The Company Confirms its Growth Strategy and R&D Outlook Lyon (France), June 30, 2017 - Valneva SE ("Valneva [...]